With the success of prostate-specific antigenscreening programs, many prost
ate cancers are being diagnosed at an earlier stage when men are more conce
rned about maintaining sexual function. Cavernous nerve preservation surger
y employed to preserve erectile function can be performed safely in the maj
ority of men undergoing radical prostatectomy. Nonetheless, as the primary
goal of any extirpative cancer operation is to remove all of the tumor, fac
tors that are associated with an increased risk of leaving a positive surgi
cal margin must be taken into consideration when evaluating a patient for n
erve preservation surgery. This article discusses contraindications to nerv
e-sparing radical prostatectomy and describes the use of standardized froze
n section analysis to help guide intraoperative decision-making regarding n
eurovascular bundle preservation.